Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Breast Neoplasms 1223Neoplasms 1028Carcinoma, Non-Small-Cell Lung 747Prostatic Neoplasms 693Colorectal Neoplasms 591Lung Neoplasms 576Leukemia, Myeloid, Acute 396Pancreatic Neoplasms 395Neoplasm Metastasis 389Ovarian Neoplasms 369Multiple Myeloma 369Stomach Neoplasms 318Carcinoma, Hepatocellular 303Melanoma 283Brain Neoplasms 281Recurrence 274Squamous Cell Carcinoma of Head and Neck 266Head and Neck Neoplasms 239Glioblastoma 235Endometrial Neoplasms 232Triple Negative Breast Neoplasms 230Lymphoma 223Precursor Cell Lymphoblastic Leukemia-Lymphoma 222Uterine Cervical Neoplasms 221Sarcoma 202Hematologic Neoplasms 202Urinary Bladder Neoplasms 198Esophageal Neoplasms 190Carcinoma, Renal Cell 188Lymphoma, Non-Hodgkin 176

Interventions

Pharmaceutical Preparations 1Irinotecan 1Fluorouracil 1Bevacizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × BRAF V600 Colorectal Cancer × 1 year × Clear all
NCT07150247 2025-09-26

Safety and Efficacy of IB-FOLFIRI in BRAF V600E-Mutant Metastatic Colorectal Cancer

Sun Yat-sen University

Phase 2 Recruiting
20 enrolled
Gastrointestinal

BRAF V600 Colorectal Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡